Cytokine profiles in early rejection following OKT3 treatment in liver transplant patients.

OKT3 , a murine monoclonal antibody specific to the human CD3 complex, induces immunosuppression by depletion of T cells. Administration of OKT3 results in significant release of proinflammatory cytokines, such as TNFalpha and IL1beta. Liver recipients who experience rejection within 3 weeks after t...

Descripción completa

Detalles Bibliográficos
Autores principales: Roayaie, S, Sheiner, P A, Emre, S, Guy, S, Schwartz, M E, Boros, P, Miller, C M
Formato: Texto
Lenguaje:English
Publicado: 2000
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1781756/
https://www.ncbi.nlm.nih.gov/pubmed/11132770

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1781756/
https://www.ncbi.nlm.nih.gov/pubmed/11132770

Ejemplares similares